ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC reported 124 positions worth $5.45B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: EWTX (11.5%). Biggest move: new buy ADRX ($482.7M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | EWTX | $630.1M | 11.46% | 15,518,492 | — | — | +7.6% | |
| ▸ 2 | ADRX | $482.7M | 8.78% | 24,205,789 | — | — | -28.8% | |
| ▸ 3 | ELVN | $310.6M | 5.65% | 6,776,632 | — | — | +3.9% | |
| ▸ 4 | LLY | $298.4M | 5.43% | 257,900 | — | — | +23.7% | |
| ▸ 5 | BRVE | $245.9M | 4.47% | 12,175,159 | — | — | -2.9% | |
| ▸ 6 | SVA | $195.5M | 3.56% | 2,718,735 | — | — | — | |
| ▸ 7 | MBX | $180.2M | 3.28% | 3,074,853 | — | — | -9.4% | |
| ▸ 8 | MRK | $137.5M | 2.50% | 946,100 | — | — | -0.6% | |
| ▸ 9 | GH | $104.2M | 1.89% | 584,100 | — | — | -19.2% | |
| ▸ 10 | AVBP | $91.7M | 1.67% | 3,027,328 | — | — | -57.0% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does ORBIMED ADVISORS LLC hold as of Q3 2026?
ORBIMED ADVISORS LLC reported 124 positions worth $5.45B in its Q3 2026 13F filing. Largest positions: EWTX (11.5%), ADRX (8.8%), ELVN (5.6%), LLY (5.4%) and BRVE (4.5%).
What did ORBIMED ADVISORS LLC buy in Q3 2026?
New positions: ADRX, BRVE, ETRA, TNGX and ABBV (33 in all). Added to: TVTX, MRK, ARQT, ASND and UNH (18 in all).
What did ORBIMED ADVISORS LLC sell in Q3 2026?
Reduced: AZN, ABVX, GPCR, NTRA and ISRG (36 in all). Sold out entirely: DYN, CGON, BSX, XENE and BMY (38 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.